Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00453401
Status:
COMPLETED
Last Update Posted:
2008-05-30
First Post:
2007-03-26
Brief Title:
Safety Pharmacokinetics and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis
Sponsor:
NanoBio Corporation
Organization:
NanoBio Corporation
Study Overview
Official Title:
The Safety Pharmacokinetics and Efficacy of NB-001 01 03 05 in Subjects With Recurrent Herpes Labialis
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose of this study is to determine the safety and efficacy of topical applications of NB-001 as compared to placebo for the treatment of recurrent herpes labialis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None